Weiguang Biotech: Report for the third quarter of 2024

SZSIOct 25 12:00 ET · Announcements

shen zhen weiguang biological products (002880.SZ) released its performance for the first three quarters, with a net income of 0.183 billion yuan, a year-on-year increase of 20.80%.

shen zhen weiguang biological products (002880.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...

Zhitong FinanceOct 25 06:01 ET

Shen Zhen Weiguang Biological Products (002880.SZ): net income of 0.183 billion yuan in the first three quarters, a year-on-year increase of 20.80%.

Shen Zhen Weiguang Biological Products (002880.SZ) announced its third quarter report for 2024 on October 25th. The company achieved revenue of 0.854 billion yuan in the first three quarters, a year-on-year increase of 16.14%; net income attributable to shareholders of the listed company was 0.183 billion yuan, a year-on-year increase of 20.80%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.178 billion yuan, a year-on-year increase of 20.48%; basic earnings per share was 0.8056 yuan.

Gelonghui FinanceOct 25 04:58 ET

Is Shenzhen Weiguang Biological Products (SZSE:002880) Using Too Much Debt?

Simply Wall StOct 14 19:31 ET

Earnings Are Growing at Shenzhen Weiguang Biological Products (SZSE:002880) but Shareholders Still Don't Like Its Prospects

Simply Wall StSep 13 21:15 ET

Weiguang Biotech: 2024 Semi-Annual Report Summary

SZSIAug 27 12:00 ET · Announcements